Repurposing rheumatology drugs for COVID-19: TNF inhibitors (with Philip Robinson)
Philip Robinson discusses why TNF inhibitors may be a favorable treatment option for COVID-19 and outlines the trials that are currently underway.
Medicine Matters rheumatology
Share:
Listens: 17
About
Interviews with clinical experts, discussing key issues in rheumatology.
Repurposing rheumatology drugs for COVID-19: Interleukin inhibitors
Cristina Mussini discusses the current data on interleukin inhibitors for the treatment of COVID-19 and explores why tocilizumab has been associated w...
Repurposing rheumatology drugs for COVID-19: JAK inhibitors
Marwan Bukhari talks about the rationale behind investigating baricitinib and other JAK inhibitors for the treatment of COVID-19 and outlines the curr...
Repurposing rheumatology drugs for COVID-19: Hydroxychloroquine (with Alfred Kim)
In this series of podcasts we are speaking to the experts about repurposing rheumatology drugs for the treatment and prevention of COVID-19. In this e...
Repurposing rheumatology drugs for COVID-19: What do we know? (with Jinoos Yazdany)
In this series of podcasts we are speaking to the experts about repurposing rheumatology drugs for the treatment and prevention of COVID-19. For the i...
A closer look at the ACR guidance on COVID-19 and rheumatology care (with Ted Mikuls)
In April 2020, the American College of Rheumatology issued guidance for the management of people with rheumatic diseases during the COVID-19 pandemic....
The COVID-19 Global Rheumatology Alliance registry: What you need to know (with Philip Robinson)
Philip Robinson, chair of the steering committee for the COVID-19 Global Rheumatology Alliance, tells us about the initiative that will enable rheumat...
COVID-19: A pediatric rheumatologist’s perspective (with Sangeeta Sule)
Sangeeta Sule, from Children’s National Hospital in Washington, DC, USA, shares her experience of how the pediatric rheumatology community is adapting...
COVID-19 in people with rheumatic diseases (with Kevin Winthrop)
Kevin Winthrop, from Oregon Health & Science University in Portland, USA, discusses why patients with rheumatic diseases may be vulnerable to COVID-19...
Discussing the guidelines for managing psoriatic arthritis: Part 2 (Dafna Gladman, Philip Mease, and Oliver FitzGerald)
In the second of a two-part series, Dafna Gladman, Philip Mease, and Oliver FitzGerald discuss the implications and limitations of the recent ACR–NPF ...